The ReCET Study

The ReCET Study

This study will investigate a new non-surgical procedure that may help lower or better control blood sugar levels for those with type 2 diabetes.

The ReCET Study

The ReCET Study

This research project will assess the safety and effectiveness of the ReCET™ device for improving blood sugar control in individuals with T2D. 

 This research is being conducted by Endogenex Inc. and sponsored in Australia by Medpace Australia Pty Ltd. 

Participation in this study will involve:

  • Undergoing the ReCET™ endoscopic procedure
  • Follow the ReCET™ diet for 4 weeks after the procedure
  • Attend a total of 17 study visits that occur across approximately 12 months at St Vincent’s Hospital, Melbourne and/or online
  • Wear a continuous glucose monitor (CGM) for 5-10 days at different points throughout the study
  • Undergo medication reviews and lifestyle counselling as part of the study visits

Learn more about the ReCET procedure in the video below or head to www.endogenex.com/recet/

To learn more about participating in this study and to determine your eligibility, visit www.recetstudy.com

Become a participant!
If you are:

  • over 22 years old
  • living with Type 2 Diabetes for at least 6 months

Then you may be a good match for this study

Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

Get involved

Please contact the Research Group Leader to discuss your options.

*All clinical trial participants must live within traveling distance of St Vincent’s Hospital Melbourne, as you will be required to attend regular clinical visits during your participation

    We collect your personal information for the purpose of contacting you and/or screening your expression of interest in study participation. It is not provided to third parties for the purposes of marketing or commercial data sharing. Your data is stored securely in a deidentified manner and is deleted permanently when no longer required. Your data may be shared with third party research collaborators in the event that they need to contact you regarding your participation once enrolled in the study. To learn more about how we store, access, use, and manage your personal data, please view the University of Melbourne Privacy Statement.

    The ReCET Study

    The ReCET Study

    This research project will assess the safety and effectiveness of the ReCET™ device for improving blood sugar control in individuals with T2D. 

     This research is being conducted by Endogenex Inc. and sponsored in Australia by Medpace Australia Pty Ltd. 

    Participation in this study will involve:

    • Undergoing the ReCET™ endoscopic procedure
    • Follow the ReCET™ diet for 4 weeks after the procedure
    • Attend a total of 17 study visits that occur across approximately 12 months at St Vincent’s Hospital, Melbourne and/or online
    • Wear a continuous glucose monitor (CGM) for 5-10 days at different points throughout the study
    • Undergo medication reviews and lifestyle counselling as part of the study visits

    Learn more about the ReCET procedure in the video below or head to www.endogenex.com/recet/

    To learn more about participating in this study and to determine your eligibility, visit www.recetstudy.com

    Become a participant!
    If you are:

    • over 22 years old
    • living with Type 2 Diabetes for at least 6 months

    Then you may be a good match for this study

    Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

    Get involved

    Please contact the Research Group Leader to discuss your options.

    *All clinical trial participants must live within traveling distance of St Vincent’s Hospital Melbourne, as you will be required to attend regular clinical visits during your participation

      We collect your personal information for the purpose of contacting you and/or screening your expression of interest in study participation. It is not provided to third parties for the purposes of marketing or commercial data sharing. Your data is stored securely in a deidentified manner and is deleted permanently when no longer required. Your data may be shared with third party research collaborators in the event that they need to contact you regarding your participation once enrolled in the study. To learn more about how we store, access, use, and manage your personal data, please view the University of Melbourne Privacy Statement.